B. Riley Wealth Advisors, Inc. - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 72 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
B. Riley Wealth Advisors, Inc. ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$86,136
-10.4%
14,550
+12.4%
0.00%0.0%
Q2 2023$96,089
-21.5%
12,9500.0%0.00%
-33.3%
Q1 2023$122,37812,9500.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Corton Capital Inc. 13,966$103,0000.13%
Delphia (USA) Inc. 14,226$105,0000.12%
Sentinus, LLC 22,500$166,0000.10%
Intrepid Financial Planning Group LLC 20,000$148,0000.08%
PERRITT CAPITAL MANAGEMENT INC 12,000$89,0000.06%
J. Goldman & Co LP 148,738$1,098,0000.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 88,966$657,0000.02%
EMFO, LLC 1,666$12,0000.01%
Virtu Financial LLC 12,590$93,0000.01%
Jump Financial, LLC 23,400$173,0000.01%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders